Announcements Trials
Browse Landscape

Phase

Phase 3 7Phase 2 4Phase 2/3 3Phase 1 2

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Conditions

Fatigue 3Neoplasms 2Prostatic Neoplasms 1Depression 1Anxiety Disorders 1

Interventions

Methylphenidate 3Melatonin 2dexamethasone acetate 1dexamethasone 21-phosphate 1auricularum 1Ultraviolet Therapy 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Sildenafil Citrate 1Radiotherapy 1Dexamethasone 1Darbepoetin alfa 1Consolidation Chemotherapy 1Cognitive Behavioral Therapy 1Chemoradiotherapy 1Calcium Dobesilate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × Fatigue × Methylphenidate × Clear all
NCT05474846 2025-11-06

Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer

M.D. Anderson Cancer Center

Phase 2/3 Recruiting
188 enrolled

Anxiety Disorders, Depression, Fatigue, Neoplasms

NCT00424099 2023-06-01

Methylphenidate and a Nursing Telephone Intervention for Fatigue

M.D. Anderson Cancer Center

Phase 2/3 Completed
197 enrolled 10 charts

Fatigue

NCT00758407 2010-01-13

EMF

Medice Arzneimittel Pütter GmbH & Co KG

Phase 2/3 Completed
66 enrolled

Fatigue, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡